Sanofi To Sell Investment In Regeneron, Says Will Not Impact Collaboration

Sanofi announced its intent to sell its equity investment in Regeneron Pharmaceuticals through a registered public offering. The registered offering and share repurchase will have no impact on the ongoing collaboration between the two.